rs143853590
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005921.2(MAP3K1):c.1846G>A(p.Gly616Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000994 in 1,614,128 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 2 hom. )
Consequence
MAP3K1
NM_005921.2 missense
NM_005921.2 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.21
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.043625057).
BS2
High AC in GnomAd4 at 112 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.1846G>A | p.Gly616Arg | missense_variant | 10/20 | ENST00000399503.4 | NP_005912.1 | |
MAP3K1 | XM_047417218.1 | c.1846G>A | p.Gly616Arg | missense_variant | 10/18 | XP_047273174.1 | ||
MAP3K1 | XM_047417219.1 | c.1435G>A | p.Gly479Arg | missense_variant | 11/21 | XP_047273175.1 | ||
MAP3K1 | XM_047417220.1 | c.1435G>A | p.Gly479Arg | missense_variant | 11/21 | XP_047273176.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K1 | ENST00000399503.4 | c.1846G>A | p.Gly616Arg | missense_variant | 10/20 | 1 | NM_005921.2 | ENSP00000382423 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000736 AC: 112AN: 152182Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
112
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000610 AC: 152AN: 249150Hom.: 0 AF XY: 0.000651 AC XY: 88AN XY: 135160
GnomAD3 exomes
AF:
AC:
152
AN:
249150
Hom.:
AF XY:
AC XY:
88
AN XY:
135160
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00102 AC: 1493AN: 1461828Hom.: 2 Cov.: 32 AF XY: 0.00101 AC XY: 734AN XY: 727214
GnomAD4 exome
AF:
AC:
1493
AN:
1461828
Hom.:
Cov.:
32
AF XY:
AC XY:
734
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000735 AC: 112AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000712 AC XY: 53AN XY: 74488
GnomAD4 genome
AF:
AC:
112
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
53
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
60
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
46,XY sex reversal 6 Pathogenic:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 10, 2010 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | Apr 09, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of methylation at G616 (P = 0.026);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at